Agenda

Articles

• FEDER
  16 March 2022, by Jonathan NOWAK

  Vect Horus a reçu l’accord de la Région Sud Provence-Alpes-Côte d’Azur, responsable de la mise en œuvre du dispositif REACT-EU dans le cadre du Programme Opérationnel FEDER-FSE, pour une subvention de 1 146 069 €.
  Vect-Horus développe sa plateforme technologique VECTrans® unique en Europe dont l’objectif est de développer des molécules « vecteurs » qui permettent le ciblage et la délivrance d’agents d’imagerie ou thérapeutiques dans des organes spécifiques. Cette stratégie est centrale, en (…)

• Vect-Horus Nominated for the 2024 Biotech Trophy Award, Organized by France Biotech
  21 March 2024, by Emmanuelle BETTENDORF

  Vect-Horus, a privately held biotechnology company that designs and develops molecular vectors that facilitate the targeted delivery of therapeutic molecules and imaging agents, today announced it has been nominated for the 2024 Biotech Trophy award, organized by the France Biotech industry association.
  The award recognizes a biotech company which has distinguished itself in the past two years by particularly remarkable advances in R&D, operational development, partnerships or (…)

• Vect-Horus will be attending BIO Europe from the 24th - 26th October in Germany
  20 October 2022, by Elodie DORMES

  This is the first in person BIOEurope since 2019 and we are excited to meet everyone face-to-face again.
  Feel free to connect with Emmanuelle BETTENDORF on the platform for a meeting/coffee to discuss our DrugDelivery platform, amongt others in Neurodegenerative, Muscular, Cardiovascular and Eye diseases.

• Vect-Horus will attend BIO International Convention in PHILADELPHIA
  25 April 2019, by Elodie DORMES

  Vect-Horus will attend BIO US in Philadelphia | June 3-6, 2019.
  If you are interested to meet, please use the B2B Partnering system.

• Meet Vect-Horus at BIO Japan, October 8-10, 202
  19 September 2025, by Emmanuelle BETTENDORF

  We are excited to be attending BioJapan, taking place October 8-10.
  Our Senior Business Developer Faustine Ramel will be in Yokohama for the event – please let us know if you would like to schedule a meeting.
  https://jcd-expo.jp/en/

• Meet Vect-Horus at BIO Spring Basel, Switzerland, March 20–22, 2023
  17 February 2023, by Elodie DORMES

  Emmanuelle BETTENDORF will participate in BioEurope Spring from March 20 to 22, 2023 and will be available to meet with you on partnership opportunities.

• BIO International Convention in BOSTON, MA
  28 January 2019, by Jonathan NOWAK

  The BIO International Convention (BIO) attracts 16,000+ biotechnology and pharma leaders who come together for one week of intensive networking to discover new opportunities and promising partnerships.
  VECT-HORUS’ business model is to make its technology platform available to pharmaceutical and biotech partners to transport their drug to the brain and other organs using feasibility studies. Subsequently, the Company will license-out its technology. VECT-HORUS is also building proprietary (…)

• Vect-Horus will participate to the HealthTech Innovation Days on November 13-14, 2022
  11 October 2022, by Elodie DORMES

  Elodie DORMES, Business Development Manager, will attend the HealthTech Innovation Days in Paris on November 13-14, 2022.
  2 days dedicated to networking and interaction with Biotech and Pharmaceutical companies.

• Vect-Horus will attend to BioJapan Digital Conference
  30 September 2021, by Elodie DORMES

  Elodie DORMES, BD Manager, will attend to the BioJapan Digital Conference, starting the 12th of October 2021 and ending the 15th of October. 4 days dedicated to digital networking and interaction with Biotech and Pharmaceutical companies needing to enhance the delivery of Key candidate compounds to the brain or other organs and tumours.

• 8th Edition of BioFIT for the first time in MARSEILLE
  4 December 2019, by Elodie DORMES

  Vect-Horus will be present at the BioFIT partnering event on December 10th, 2019 in Marseille.